A longstanding goal has been to determine whether androgen receptor (AR) levels could be used to predict the clinical response of metastatic prostate cancer to androgen withdrawal therapy. A major limitation of previous studies was the use of homogenized tissue, which yields an average AR content fo
โฆ LIBER โฆ
Image analysis of androgen receptor immunostaining in metastatic prostate cancer heterogeneity as a predictor of response to hormonal therapy
โ Scribed by Marcus V. Sadi; Evelyn R. Barrack
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 609 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Immunohistochemical study of androgen re
โ
Marcus V. Sadi; Patrick C. Walsh; Evelyn R. Barrack
๐
Article
๐
1991
๐
John Wiley and Sons
๐
English
โ 867 KB
Estimating survival gain for economic ev
โ
N. Neymark; I. Adriaenssen; T. Gorlia; S. Caleo; M. Bolla
๐
Article
๐
2002
๐
John Wiley and Sons
๐
English
โ 240 KB
๐ 1 views
## Abstract The problem of estimating expected outcomes for the economic evaluation of treatments for which the outcome of principal interest is (quality adjusted) survival time has so far not received sufficient attention in the literature. The best estimate of expected survival is mean survival t